Información de la publicación

Portal del Investigador > Publicaciones > detalle publicacion

Detalle_Publicacion

CD133-directed CAR T-cells for MLL Leukemia: On-Target, Off-Tumor Myeloablative Toxicity

Otras publicaciones de la misma revista o congreso con autores/as de la Universidad de Cantabria

Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis - Artículo de Revista
Isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients with renal impairment: ICARIA-MM subgroup analysis - Artículo de Revista
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma - Artículo de Revista
The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma - Artículo de Revista
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms - Artículo de Revista
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia - Artículo de Revista
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma - Artículo de Revista
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation - Artículo de Revista
Skin lesions, arthritis, chondritis, and cytopenias - Artículo de Revista
Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody. - Artículo de Revista
Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture - Artículo de Revista
A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control - Artículo de Revista
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia - Artículo de Revista
In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone. - Artículo de Revista
Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification. - Artículo de Revista
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG). - Artículo de Revista
Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential - Artículo de Revista
The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects. - Artículo de Revista
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm - Artículo de Revista
Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma - Artículo de Revista
Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation - Artículo de Revista
HDAC7 is a major contributor in the pathogenesis of infant t(4;11) proB acute lymphoblastic leukemia - Artículo de Revista

Fuente: Leukemia, 33 (8), 2090-2125 Aug 2019

Editorial: Nature Publishing Group

Año de publicación: 2019

Nº de páginas: 4

Tipo de publicación: Artículo de Revista

DOI: 10.1038/s41375-019-0418-8

ISSN: 0887-6924,1476-5551

Proyecto español: SAF-SAF2016-80481- R

Url de la publicación: https://doi.org/10.1038/s41375-019-0418-8

Consultar en UCrea Leer publicación

Autoría

BUENO, CLARA

VELASCO-HERNANDEZ, TALIA

GUTIÉRREZ-AGÜERA, FRANCISCO

ZANETTI, SAMANTA ROMINA

BARONI, MATTEO L.

SÁNCHEZ-MARTÍNEZ, DIEGO

MOLINA, OSCAR

CLOSA, ADRIA

AGRAZ-DOBLÁS, ANTONIO

MARÍN, PEDRO

EYRAS, EDUARDO

IGNACIO VARELA EGOCHEAGA

MENÉNDEZ, PABLO

Descargar referencia

Bib Ris

Volver

Researchers portal

Portal del personal investigador

Detalle_Publicacion

CD133-directed CAR T-cells for MLL Leukemia: On-Target, Off-Tumor Myeloablative Toxicity

Autoría

Descargar referencia